Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENS for Premature Ejaculation
NCT04207723Completed
- Sponsor
- Boston Medical Corporation
- Start
- Jul 2020
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in premature ejaculation (PE) (3 arms), sponsored by Boston Medical Corporation. Primary endpoint: Intravaginal Latency Time at 12 weeks. Started Jul 2020; status: completed.
02
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT04207723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04207723.